港股異動 | 農夫山泉(9633.HK)一度跌逾6% 一款氣泡水捲入福島原料爭議
格隆匯6月28日丨農夫山泉(9633.HK)一度跌逾6%,現跌幅收窄至約2%,報40.3港元,總市值4532億港元。近日,農夫山泉深陷氣泡水原料的輿論漩渦。6月28日,農夫山泉官方在微博迴應稱,旗下氣泡水產品配料中沒有從日本福島進口的成分,“並無任何錯誤或誤導”。按照農夫山泉的迴應,這款白桃味氣泡水其實只是“調味飲料”,與拂曉白桃沒有半毛線的關係。不少網友在評論區中表示,是農夫山泉自身在廣吿中大肆宣傳飲料的“白桃”成分,現在卻矢口否認。在此之前,監管也對此事進行了現場檢查,結論是沒有采用福島的生產原料。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.